← FDA Drug Approvals (Drugs@FDA)

KYNMOBI

NDA · New Drug Application · Sponsor: SUMITOMO PHARMA AM · Approved 2020-05-21

Drug application

FDA Application #

NDA210875

Application type

New Drug Application

Brand name

KYNMOBI

Generic name

Apomorphine Hydrochloride

Active ingredients

APOMORPHINE HYDROCHLORIDE

Dosage form

FILM

Route

SUBLINGUAL

Marketing status

Discontinued

Sponsor

SUMITOMO PHARMA AM

First approval

2020-05-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown